期刊文献+

四联与三联疗法在胃溃疡合并幽门螺杆菌感染治疗中的应用效果比较 被引量:8

A comparison of application effect between quadruple and triple therapy on gastric ulcer complicated with Helicobacter pylori infection
下载PDF
导出
摘要 目的比较胃溃疡合并幽门螺杆菌(Hp)感染治疗中四联与三联疗法的应用效果。方法选取六盘水市人民医院2011—2013年收治的胃溃疡合并Hp感染患者86例,按照治疗方案分为三联组(雷贝拉唑+阿莫西林+克拉霉素)和四联组(雷贝拉唑+阿莫西林+克拉霉素+胶体果胶铋),每组43例。比较两组患者的临床疗效、Hp清除率及不良反应发生率。结果四联组患者总有效率(88.4%)高于三联组(69.8%)(P<0.05)。四联组患者Hp清除率为86.1%(37/43),高于三联组的67.4%(29/43),差异有统计学意义(P<0.05);两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。结论四联疗法治疗胃溃疡合并Hp感染的效果显著,能有效提高Hp清除率,且具有一定的安全性。 objective To compare the application effect between quadruple and triple therapy in the treatment of gas-tric ulcer complicated with Helicobacter pylori( Hp) infection. Methods A total of 86 gastric ulcer patients complicated with Hp infection were selected in the People&#39;s Hospital of Liupanshui from 2011 to 2013,and they were divided into triple therapy group( rabeprazole+amoxicillin+clarithromycin) and quadruple therapy group( rabeprazole+amoxicillin+clarithromycin+colloidal bismuth pectin),43 cases in each group. Curative effect,Hp clearance rate and incidence of adverse reactions between the two groups were compared. Results The total effective rate of quadruple therapy group(88. 4%) was higher than that of triplet therapy group(69. 8%)(P〈0. 05). The HP clearance rate of quadruple therapy group(86. 1%)was higher than that of triple therapy group(67. 4%)(P〈 0. 05). There was no significant differences of incidence of adverse reactions be-tween the two groups(P 〉0. 05). Conclusion Quadruple therapy has remarkable effect in the treatment of gastric ulcer com-plicated with Hp infection,can effectively improve the Hp clearance rate and is safe.
作者 田琰
出处 《临床合理用药杂志》 2015年第9期15-16,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 胃溃疡 幽门螺杆菌 四联疗法 三联疗法 治疗结果 Stomach ulcer Helicobacter pylori Quadruple therapy Triple therapy Treatment outcome
  • 相关文献

参考文献10

二级参考文献62

共引文献127

同被引文献67

  • 1刘东红.微生态制剂的进展与临床应用评价[J].中国医院用药评价与分析,2006,6(3):139-142. 被引量:55
  • 2成虹,胡伏莲,谢勇,胡品津,王吉耀,吕农华,张建中,张桂英,周曾芬,吴克利,张玲霞,彭孝伟,戴宁,唐国都,姜葵,李岩,侯晓华,白文元,王明春,叶红军,刘玉兰,许乐.中国幽门螺杆菌耐药状况以及耐药对治疗的影响—全国多中心临床研究[J].胃肠病学,2007,12(9):525-530. 被引量:517
  • 3陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 4赵静,邱学家.运用成本:效果分析法对基本药物进行经济学评价[J].药业论坛,2010,14(19): 17-18.
  • 5Adamu MA, Weck MN, Rothenbacher D, et al. Incidence and risk factors for the development of chronic atrophic gastritis: five year follow-up of a population-based cohort study[J].Int J Cancer, 2011, 128(7): 1652-1658.
  • 6Malfertheiner P1, Megraud F, O'Morain CA, et al. Manage- ment of Helicobacter pylori infection--the Maastrieht IV/ Flor- ence Consensus Report[J]. Gut. 2012, 61(5): 646-664.
  • 7Schrezenmeir J, de Vrese M. Probiotics, prebiotics and synbiot- ics--approaching a definition[J]. Am J Clin Nutr, 2001, 73: 361S-364S.
  • 8Valeur N, Engel P, Carbajal N, et al. Colonization and immu- nomodulation by Lactobacillus reuteri ATCC 55730 in the hu- man gastrointestinal traet[J]. Appl Environ Mierobiol, 2004, 70(2): 1176-1181.
  • 9Armuzzi A, Cremonini F, Ojetti V, et al. Effect of Lactobacil- lus GG supplementation on antibioticassociated gastrointestinal side effects during Helicobacter pylori eradication therapy~ a pi- lot study[J]. Digestion, 2001, 63(1): 1-7.
  • 10Park SK, Park DI, Choi JS, et al. The effect of probiotics on Helicobacter pylori eradication [J]. Hepatogastroenterology, 2007, 54(79): 2032-2036.

引证文献8

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部